Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Total Liabilities: 2022-2025

Historic Total Liabilities for bioAffinity Technologies (BIAF) over the last 3 years, with Sep 2025 value amounting to $2.6 million.

  • bioAffinity Technologies' Total Liabilities fell 22.93% to $2.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 22.93%. This contributed to the annual value of $3.9 million for FY2024, which is 16.20% up from last year.
  • bioAffinity Technologies' Total Liabilities amounted to $2.6 million in Q3 2025, which was down 61.61% from $6.9 million recorded in Q2 2025.
  • bioAffinity Technologies' 5-year Total Liabilities high stood at $6.9 million for Q2 2025, and its period low was $775,151 during Q2 2023.
  • For the 3-year period, bioAffinity Technologies' Total Liabilities averaged around $3.2 million, with its median value being $3.2 million (2024).
  • As far as peak fluctuations go, bioAffinity Technologies' Total Liabilities spiked by 315.83% in 2024, and later dropped by 22.93% in 2025.
  • bioAffinity Technologies' Total Liabilities (Quarterly) stood at $1.1 million in 2022, then soared by 195.63% to $3.4 million in 2023, then grew by 16.20% to $3.9 million in 2024, then dropped by 22.93% to $2.6 million in 2025.
  • Its Total Liabilities was $2.6 million in Q3 2025, compared to $6.9 million in Q2 2025 and $4.1 million in Q1 2025.